Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novartis pharma gmbh - germania - octreotidum - pulb. si solv. pt. susp. inj. - 30mg - hormoni hipotalamici hormoni anticrestere

Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novartis pharma gmbh - germania - octreotidum - sol. inj./perf. - 0,1mg/ml - hormoni hipotalamici hormoni anticrestere

Սերբիա - սերբերեն - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

predstavniŠtvo novartis pharma services inc. beograd (novi beograd) - Октреотид -

Գերմանիա - գերմաներեն - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

novartis pharma gmbh (8011799) - octreotidacetat (1:x) ((mit angaben zum essigsäure-gehalt)) - pulver und lösungsmittel zur herstellung einer injektionssuspension - octreotidacetat (1:x) ((mit angaben zum essigsäure-gehalt)) (23738) 33,6 milligramm

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - octreotide - injection - 0.1 mg/ml - octreotide 0.1 mg/ml

Իսրայել - անգլերեն - Ministry of Health

novartis israel ltd - octreotide - solution for injection / infusion - octreotide 0.2 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerothera

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - octreotide acetate 11.2mg eqv octreotide - injection - 10 mg/vial - octreotide acetate 11.2mg eqv octreotide 10 mg/vial

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - octreotide acetate 22.4mg eqv octreotide - injection - 20 mg/vial - octreotide acetate 22.4mg eqv octreotide 20 mg/vial

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - octreotide acetate 33.6mg eqv octreotide - injection - 30 mg/vial - octreotide acetate 33.6mg eqv octreotide 30 mg/vial

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base - solution for injection - 0.05 mg/ml - active: octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection